The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices

Kane Biotech Inc closed at $0.03.

Although unchanged over the last five days, shares are down 40.00% for the last year to date. This security has underperformed the S&P TSX by 30.39% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.02
Updated at previous session's close. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-1,634.49%

Although this company's net profit margin is negative, it is above the industry average and implies that Kane Biotech Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Biotechnology

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit0000
Total cost of revenue0000
Total operating expense0000
Selling / general / administrative0000
Research & development0000
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total000--
Operating income0000
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets000--
Other--------
Income before tax0000
Income after tax0000
Income tax, total--------
Net income0000
Total adjustments to net income--------
Net income before extra. items0000
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items0000
Inc. avail. to common incl. extra. items0000
Diluted net income0000
Dilution adjustment------0
Diluted weighted average shares114108107107
Diluted EPS excluding extraordinary itemsvalue per share0.000.000.000.00
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.000.000.000.00